ROME and MILAN, Jan. 14, 2025 /PRNewswire/ -- Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics. Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that...
Hence then, the article about enea tech and biomedical foundation invests 15 million in tethis to develop new diagnostic methods in oncology using liquid biopsy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy )
Also on site :
- Microsoft, Meta, and Google just announced billions more in AI spending. Only Google convinced investors it’s paying off
- Meta’s AI Is Delivering but Comes With a Hefty Price Tag .. PYMNTS.com
- 2026 Billboard Women in Music Red Carpet: The Best Photos